Birch Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Birch Capital Management's ABBV Position: Q2 2026 in Review
Birch Capital Management reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $74.9K and leaving 4,266 shares worth $1.07M. The position accounts for 0.52% of the portfolio, ranked #42.
Birch Capital Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.1M in Q1 2022. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Birch Capital Management held 4,266 shares of AbbVie worth $1.07M as of Q2 2026.
- Birch Capital Management sold 348 AbbVie shares in Q2 2026, an estimated $74.9K.
- AbbVie made up 0.52% of Birch Capital Management's portfolio in Q2 2026, its #42 holding.
- Birch Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
- Birch Capital Management's AbbVie position peaked at $2.1M in Q1 2022.
- 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Birch Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.